Hot Clean Energy Stocks To Watch Right Now


Investment company Doheny Asset Management buys Euronav NV, Energous Corp, Aqua Metals Inc, Netflix Inc, Facebook Inc, SRC Energy Inc, Tesla Inc, Enbridge Inc, GW Pharmaceuticals PLC, Goldman Sachs Group Inc, sells Exar Corp, Frontier Communications Corp, Gilead Sciences Inc, Check Point Software Technologies, East West Bancorp Inc during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Doheny Asset Management . As of 2017-03-31, Doheny Asset Management owns 114 stocks with a total value of $221 million. These are the details of the buys and sells.

New Purchases: NFLX, FB, SRCI, TSLA, ENB, GS, GWPH, AZN, MA, Added Positions: EURN, WATT, AQMS, BGCP, BP, LXP, WFC, SFL, T, NAT, Reduced Positions: EXAR, FTR, GILD, CHKP, EWBC, VZ, QCOM, MCHP, AAPL, XOM, Sold Out: SE, DFS, UTX,

For the details of DOHENY ASSET MANAGEMENT ‘s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=DOHENY+ASSET+MANAGEMENT+


These are the top 5 holdings of DOHENY ASSET MANAGEMENT Aqua Metals Inc (AQMS) – 789,425 shares, 6.97% of the total portfolio. Shares added by 26.17%Energous Corp (WATT) – 969,676 shares, 6.83% of the total portfolio. Shares added by 27.79%Apple Inc (AAPL) – 91,276 shares, 5.92% of the total portfolio. Shares reduced by 5.65%Ship Finance International Ltd (SFL) – 626,609 shares, 4.16% of the total portfolio. Shares added by 2.12%BGC Partners Inc (BGCP) – 780,417 shares, 4.01% of the total portfolio. Shares added by 4.70%New Purchase: Netflix Inc (NFLX)


Doheny Asset Management initiated holdings in Netflix Inc. The purchase prices were between $127.49 and $148.06, with an estimated average price of $140.31. The stock is now traded at around $160.46. The impact to the portfolio due to this purchase was 0.48%. The holdings were 7,160 shares as of 2017-03-31.

Hot Clean Energy Stocks To Watch Right Now: GAIN Capital Holdings, Inc.(GCAP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, financial shares fell 0.16 percent. Meanwhile, top losers in the sector included Federated National Holding Co (NASDAQ: FNHC), down 11 percent, and Gain Capital Holdings Inc (NYSE: GCAP), down 7 percent.

  • [By Lisa Levin]

    FXCM Inc (NASDAQ: FXCM) shares dropped 53 percent to $3.24 after the company announced regulatory settlements with NFA and CFTC against its U.S. subsidiary, Forex Capital Markets LLC. Gain Capital Holdings Inc (NYSE: GCAP) agreed to acquire the client base of FXCM's U.S. operations after FXCM reported that it will be withdrawing from U.S. business.

Hot Clean Energy Stocks To Watch Right Now: Huntington Ingalls Industries, Inc.(HII)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Huntington Ingalls Industries (HII) is the largest repairer and ship builder for the U.S. Navy and U.S. coast guard, giving the company a near monopoly on these government contracts (which is why their return on equity is north of 27%).

  • [By Rich Smith]

    Huntington Ingalls’ (NYSE:HII) Ford-class supercarrier seems one likely suspect — and at $14 billiona pop, this gigantic aircraft carrier offers a big potential target for Trump’s next tweet storm.

  • [By Rich Smith]

    As details about the Pentagon’s plan have emerged, it’s become clear that this will be a sizable program, amounting to perhaps $1 trillion in spending over 30 years — not just to upgrade the Minuteman missiles, but also to buy new B-21 stealth bombers from Northrop Grumman (NYSE:NOC)and have General Dynamics (NYSE:GD) and Huntington Ingalls (NYSE:HII) design an entirely new class of ballistic missile submarines (to be known as the “Columbia class.”)

Hot Clean Energy Stocks To Watch Right Now: Medtronic plc(MDT)


Advisors’ Opinion:

  • [By Todd Campbell]

    At Medtronic (NYSE:MDT), one of the country’s largest medical-device companies, these sensors are even attached to an insulin pump patients wear that canautomatically administer insulin as it’s needed.

  • [By James E. Brumley]

    When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.


    General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.

    Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.


    The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.

    Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It

  • [By Ben Levisohn]

    Medtronic (MDT) has risen 1.9% to $81.75 on reports that Cardinal Health (CAH) will buy its medical supplies business.

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

Leave a Reply

Your email address will not be published.